Molecule Holdings Inc.
EVRRF · OTC
10/31/2022 | 10/31/2021 | 10/31/2020 | 10/31/2019 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.40 | -0.13 | 0.19 | 0.00 |
| FCF Yield | -36.61% | -7.20% | -5.09% | -68.85% |
| EV / EBITDA | -2.54 | -15.35 | -17.17 | -1.91 |
| Quality | ||||
| ROIC | -250.72% | -62.11% | -43.16% | -23.73% |
| Gross Margin | -54.56% | -109.77% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.25 | 0.68 | 0.28 | 0.83 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | -100.00% | -100.00% |
| Free Cash Flow Growth | 60.54% | -4.29% | -0.81% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | -1.57 | -1.13 | 0.01 | 1.98 |
| Interest Coverage | -6.17 | -4.83 | -42.13 | -69.34 |
| Efficiency | ||||
| Inventory Turnover | 5.01 | 1.49 | 0.33 | 0.00 |
| Cash Conversion Cycle | -81.23 | 274.78 | -6,160.79 | -6,676.96 |